Discover how the FDA's approval of Vetmedin, the first drug to delay congestive heart failure in dogs, is transforming canine ...
Congenital heart disease (CHD) in dogs encompasses a spectrum of structural cardiac abnormalities present from birth, often resulting from genetic predispositions and environmental influences during ...
Jan 19 (Reuters) - Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable tablet, as the first drug to delay congestive heart ...
DULUTH, Ga., Jan. 19, 2026 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, today announced that the U.S. Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results